Improved Stabilization and Reduction of Particulate Formation in Protein Drug Formulations Using Recombinant Human Albumin (rAlbumin Human USP-NF)

This poster demonstrates that a recombinant HSA (rAlbumin) derived from yeast is a safe excipient candidate with a well-documented stabilizing effect including aggregation prevention in liquid and lyophilized protein formulations and also prevention of drug depletion and degradation caused by surface adsorption/effects.